Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes

Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukoc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patrycja Leszczenko, Aleksandra Borek-Dorosz, Anna Maria Nowakowska, Adriana Adamczyk, Sviatlana Kashyrskaya, Justyna Jakubowska, Marta Ząbczyńska, Agata Pastorczak, Kinga Ostrowska, Malgorzata Baranska, Katarzyna Maria Marzec, Katarzyna Majzner
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b23478871ab340618ebc3930ee9d4788
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b23478871ab340618ebc3930ee9d4788
record_format dspace
spelling oai:doaj.org-article:b23478871ab340618ebc3930ee9d47882021-11-11T15:33:40ZTowards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes10.3390/cancers132154832072-6694https://doaj.org/article/b23478871ab340618ebc3930ee9d47882021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5483https://doaj.org/toc/2072-6694Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukocytosis, and the response to chemotherapy. Currently, treatment intensity is modified according to the presence of specific gene alterations in the leukemic genome. Raman imaging is a promising diagnostic tool, which enables the molecular characterization of cells and differentiation of subtypes of leukemia in clinical samples. This study aimed to characterize and distinguish cells isolated from the bone marrow of patients suffering from three subtypes of BCP-ALL, defined by gene rearrangements, i.e., <i>BCR-ABL1</i> <i>(Philadelphia</i>-positive, t(9;22)), <i>TEL-AML1</i> (t(12;21)) and <i>TCF3-PBX1</i> (t(1;19)), using single-cell Raman imaging combined with multivariate statistical analysis. Spectra collected from clinical samples were compared with single-cell spectra of B-cells collected from healthy donors, constituting the control group. We demonstrated that Raman spectra of normal B cells strongly differ from spectra of their malignant counterparts, especially in the intensity of bands, which can be assigned to nucleic acids. We also showed that the identification of leukemia subtypes could be automated with the use of chemometric methods. Results prove the clinical suitability of Raman imaging for the identification of spectroscopic markers characterizing leukemia cells.Patrycja LeszczenkoAleksandra Borek-DoroszAnna Maria NowakowskaAdriana AdamczykSviatlana KashyrskayaJustyna JakubowskaMarta ZąbczyńskaAgata PastorczakKinga OstrowskaMalgorzata BaranskaKatarzyna Maria MarzecKatarzyna MajznerMDPI AGarticleRaman spectroscopyacute lymphoblastic leukemia (ALL)fusion geneschemometric techniques<i>BCR-ABL1</i><i>TCF-PBX1</i>Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5483, p 5483 (2021)
institution DOAJ
collection DOAJ
language EN
topic Raman spectroscopy
acute lymphoblastic leukemia (ALL)
fusion genes
chemometric techniques
<i>BCR-ABL1</i>
<i>TCF-PBX1</i>
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Raman spectroscopy
acute lymphoblastic leukemia (ALL)
fusion genes
chemometric techniques
<i>BCR-ABL1</i>
<i>TCF-PBX1</i>
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Patrycja Leszczenko
Aleksandra Borek-Dorosz
Anna Maria Nowakowska
Adriana Adamczyk
Sviatlana Kashyrskaya
Justyna Jakubowska
Marta Ząbczyńska
Agata Pastorczak
Kinga Ostrowska
Malgorzata Baranska
Katarzyna Maria Marzec
Katarzyna Majzner
Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
description Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukocytosis, and the response to chemotherapy. Currently, treatment intensity is modified according to the presence of specific gene alterations in the leukemic genome. Raman imaging is a promising diagnostic tool, which enables the molecular characterization of cells and differentiation of subtypes of leukemia in clinical samples. This study aimed to characterize and distinguish cells isolated from the bone marrow of patients suffering from three subtypes of BCP-ALL, defined by gene rearrangements, i.e., <i>BCR-ABL1</i> <i>(Philadelphia</i>-positive, t(9;22)), <i>TEL-AML1</i> (t(12;21)) and <i>TCF3-PBX1</i> (t(1;19)), using single-cell Raman imaging combined with multivariate statistical analysis. Spectra collected from clinical samples were compared with single-cell spectra of B-cells collected from healthy donors, constituting the control group. We demonstrated that Raman spectra of normal B cells strongly differ from spectra of their malignant counterparts, especially in the intensity of bands, which can be assigned to nucleic acids. We also showed that the identification of leukemia subtypes could be automated with the use of chemometric methods. Results prove the clinical suitability of Raman imaging for the identification of spectroscopic markers characterizing leukemia cells.
format article
author Patrycja Leszczenko
Aleksandra Borek-Dorosz
Anna Maria Nowakowska
Adriana Adamczyk
Sviatlana Kashyrskaya
Justyna Jakubowska
Marta Ząbczyńska
Agata Pastorczak
Kinga Ostrowska
Malgorzata Baranska
Katarzyna Maria Marzec
Katarzyna Majzner
author_facet Patrycja Leszczenko
Aleksandra Borek-Dorosz
Anna Maria Nowakowska
Adriana Adamczyk
Sviatlana Kashyrskaya
Justyna Jakubowska
Marta Ząbczyńska
Agata Pastorczak
Kinga Ostrowska
Malgorzata Baranska
Katarzyna Maria Marzec
Katarzyna Majzner
author_sort Patrycja Leszczenko
title Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
title_short Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
title_full Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
title_fullStr Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
title_full_unstemmed Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes
title_sort towards raman-based screening of acute lymphoblastic leukemia-type b (b-all) subtypes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b23478871ab340618ebc3930ee9d4788
work_keys_str_mv AT patrycjaleszczenko towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT aleksandraborekdorosz towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT annamarianowakowska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT adrianaadamczyk towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT sviatlanakashyrskaya towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT justynajakubowska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT martazabczynska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT agatapastorczak towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT kingaostrowska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT malgorzatabaranska towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT katarzynamariamarzec towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
AT katarzynamajzner towardsramanbasedscreeningofacutelymphoblasticleukemiatypebballsubtypes
_version_ 1718435205494079488